{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:29:35Z","timestamp":1788827375179,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41440-025-02428-0","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:17:16Z","timestamp":1760941036000},"page":"3101-3112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elevated sFlt-1\/PlGF ratio in women with suspected or confirmed early-onset preeclampsia and super-imposed preeclampsia complicated by HELLP syndrome as well as abnormal umbilical artery Doppler findings and non-reassuring fetal status requiring immediate delivery: a prospective cohort study"],"prefix":"10.1038","volume":"48","author":[{"given":"Akihide","family":"Ohkuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotada","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ogoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"2428_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr\u00f6m M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13\u201322.","journal-title":"N Engl J Med"},{"key":"2428_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","volume":"74","author":"X Bian","year":"2019","unstructured":"Bian X, Biswas A, Huang X, Lee KJ, Li TK, Masuyama H, et al. Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia. Hypertension. 2019;74:164\u201372.","journal-title":"Hypertension"},{"key":"2428_CR3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41440-021-00629-x","volume":"44","author":"A Ohkuchi","year":"2021","unstructured":"Ohkuchi A, Saito S, Yamamoto T, Minakami H, Masuyama H, Kumasawa K, et al. Short-term prediction of preeclampsia using the sFlt-1\/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study. Hypertens Res. 2021;44:813\u201321.","journal-title":"Hypertens Res"},{"key":"2428_CR4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","volume":"125","author":"S Rana","year":"2012","unstructured":"Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125:911\u20139.","journal-title":"Circulation"},{"key":"2428_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.preghy.2013.02.003","volume":"3","author":"L De Oliveira","year":"2013","unstructured":"De Oliveira L, Pera\u00e7oli JC, Pera\u00e7oli MT, Korkes H, Zampieri G, Moron AF, et al. sFlt-1\/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia. Pregnancy Hypertens. 2013;3:191\u20135.","journal-title":"Pregnancy Hypertens"},{"key":"2428_CR6","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.111.00754","volume":"61","author":"A Lea\u00f1os-Miranda","year":"2013","unstructured":"Lea\u00f1os-Miranda A, Campos-Galicia I, Ram\u00edrez-Valenzuela KL, Chinolla-Arellano ZL, Isordia-Salas I. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia. Hypertension. 2013;61:1118\u201325.","journal-title":"Hypertension"},{"key":"2428_CR7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/uog.13224","volume":"43","author":"PI G\u00f3mez-Arriaga","year":"2014","unstructured":"G\u00f3mez-Arriaga PI, Herraiz I, L\u00f3pez-Jim\u00e9nez EA, Escribano D, Denk B, Galindo A. Uterine artery Doppler and sFlt-1\/PlGF ratio: prognostic value in early-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2014;43:525\u201332.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2428_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/14767058.2013.806905","volume":"27","author":"T Chaiworapongsa","year":"2014","unstructured":"Chaiworapongsa T, Romero R, Korzeniewski SJ, Cortez JM, Pappas A, Tarca AL, et al. Plasma concentrations of angiogenic\/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med. 2014;27:132\u201344.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2428_CR9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/pd.4554","volume":"35","author":"GE Palomaki","year":"2015","unstructured":"Palomaki GE, Haddow JE, Haddow HR, Salahuddin S, Geahchan C, Cerdeira AS, et al. Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenat Diagn. 2015;35:386\u201393.","journal-title":"Prenat Diagn"},{"key":"2428_CR10","doi-asserted-by":"crossref","first-page":"89.e1","DOI":"10.1016\/j.ajog.2016.01.168","volume":"215","author":"K Baltajian","year":"2016","unstructured":"Baltajian K, Bajracharya S, Salahuddin S, Berg AH, Geahchan C, Wenger JB, et al. Sequential plasma angiogenic factors levels in women with suspected preeclampsia. Am J Obstet Gynecol. 2016;215:89.e1\u201389.e10.","journal-title":"Am J Obstet Gynecol"},{"key":"2428_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejogrb.2016.02.013","volume":"199","author":"L Saleh","year":"2016","unstructured":"Saleh L, Verdonk K, Jan Danser AH, Steegers EA, Russcher H, van den Meiracker AH, et al. The sFlt-1\/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort. Eur J Obstet Gynecol Reprod Biol. 2016;199:121\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2428_CR12","doi-asserted-by":"crossref","first-page":"e6005","DOI":"10.1097\/MD.0000000000006005","volume":"96","author":"A Lea\u00f1os-Miranda","year":"2017","unstructured":"Lea\u00f1os-Miranda A, M\u00e9ndez-Aguilar F, Ram\u00edrez-Valenzuela KL, Serrano-Rodr\u00edguez M, Berumen-Lechuga G, Molina-P\u00e9rez CJ, et al. Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes. Medicine. 2017;96:e6005.","journal-title":"Medicine"},{"key":"2428_CR13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.117.09913","volume":"70","author":"L Saleh","year":"2017","unstructured":"Saleh L, Vergouwe Y, van den Meiracker AH, Verdonk K, Russcher H, Bremer HA, et al. Angiogenic markers predict pregnancy complications and prolongation in preeclampsia: continuous versus cutoff values. Hypertension. 2017;70:1025\u201333.","journal-title":"Hypertension"},{"key":"2428_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10641955.2018.1494188","volume":"37","author":"AM Abbas","year":"2018","unstructured":"Abbas AM, Fikry EM, Mostafa TS, Shaltout AS, El-Baz MAH. Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study. Hypertens Pregnancy. 2018;37:137\u201343.","journal-title":"Hypertens Pregnancy"},{"key":"2428_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","volume":"77","author":"LA Dr\u00f6ge","year":"2021","unstructured":"Dr\u00f6ge LA, Perschel FH, St\u00fctz N, Gafron A, Frank L, Busjahn A, et al. Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study. Hypertension. 2021;77:461\u201371.","journal-title":"Hypertension"},{"key":"2428_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preghy.2020.09.009","volume":"22","author":"L Mirkovic","year":"2020","unstructured":"Mirkovic L, Tulic I, Stankovic S, Soldatovic I. Prediction of adverse maternal outcomes of early severe preeclampsia. Pregnancy Hypertens. 2020;22:144\u201350.","journal-title":"Pregnancy Hypertens"},{"key":"2428_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/1471-0528.16383","volume":"128","author":"A Peguero","year":"2021","unstructured":"Peguero A, Fernandez-Blanco L, Mazarico E, Benitez L, Gonzalez A, Youssef L, et al. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study. BJOG. 2021;128:158\u201365.","journal-title":"BJOG"},{"key":"2428_CR18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.23142","volume":"58","author":"L Saleh","year":"2021","unstructured":"Saleh L, Alblas MM, Nieboer D, Neuman RI, Vergouwe Y, Bruss\u00e9 IA, et al. Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model. Ultrasound Obstet Gynecol. 2021;58:698\u2013704.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2428_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preghy.2020.07.007","volume":"22","author":"E Sim\u00f3n","year":"2020","unstructured":"Sim\u00f3n E, Permuy C, Sacrist\u00e1n L, Zamoro-Lorenci MJ, Villala\u00edn C, Galindo A, et al. sFlt-1\/PlGF ratio for the prediction of delivery within 48\u2009h and adverse outcomes in expectantly managed early-onset preeclampsia. Pregnancy Hypertens. 2020;22:17\u201323.","journal-title":"Pregnancy Hypertens"},{"key":"2428_CR20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/uog.24851","volume":"59","author":"M Reddy","year":"2022","unstructured":"Reddy M, Palmer K, Rolnik DL, Wallace EM, Mol BW, Da Silva Costa F. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia. Ultrasound Obstet Gynecol. 2022;59:596\u2013605.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2428_CR21","doi-asserted-by":"crossref","first-page":"EVIDoa2200161","DOI":"10.1056\/EVIDoa2200161","volume":"1","author":"R Thadhani","year":"2022","unstructured":"Thadhani R, Lemoine E, Rana S, Costantine MM, Calsavara VF, Boggess K, et al. Circulating angiogenic ffactor levels in hypertensive disorders of pregnancy. NEJM Evid. 2022;1:EVIDoa2200161.","journal-title":"NEJM Evid"},{"key":"2428_CR22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/uog.26276","volume":"62","author":"J Binder","year":"2023","unstructured":"Binder J, Palmrich P, Kalafat E, Haberl C, Schirwani N, Pateisky P, et al. Longitudinal assessment of angiogenic markers in prediction of adverse outcome in women with confirmed pre-eclampsia. Ultrasound Obstet Gynecol. 2023;62:843\u201351.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2428_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00404-019-05365-9","volume":"301","author":"O Graupner","year":"2020","unstructured":"Graupner O, Karge A, Flechsenhar S, Seiler A, Haller B, Ortiz JU, et al. Role of sFlt-1\/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia. Arch Gynecol Obstet. 2020;301:375\u201385.","journal-title":"Arch Gynecol Obstet"},{"key":"2428_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preghy.2023.04.004","volume":"32","author":"A Peguero","year":"2023","unstructured":"Peguero A, Fernandez-Blanco L, Mazarico E, Benitez L, Gonzalez A, et al. Prediction of adverse neonatal outcome at admission for early-onset preeclampsia with severe features. Pregnancy Hypertens. 2023;32:64\u20139.","journal-title":"Pregnancy Hypertens"},{"key":"2428_CR25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/hr.2010.212","volume":"34","author":"C Hirashima","year":"2011","unstructured":"Hirashima C, Ohkuchi A, Takahashi K, Suzuki H, Yoshida M, Ohmaru T, et al. Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors. Hypertens Res. 2011;34:212\u20137.","journal-title":"Hypertens Res"},{"key":"2428_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10641950802419895","volume":"28","author":"A Ohkuchi","year":"2009","unstructured":"Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Usui R, et al. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria. Hypertens Pregnancy. 2009;28:95\u2013108.","journal-title":"Hypertens Pregnancy"},{"key":"2428_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","volume":"124","author":"I Herraiz","year":"2014","unstructured":"Herraiz I, Dr\u00f6ge LA, G\u00f3mez-Montes E, Henrich W, Galindo A, Verlohren S. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction. Obstet Gynecol. 2014;124:265\u201373.","journal-title":"Obstet Gynecol"},{"key":"2428_CR28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/HYPERTENSIONAHA.111.174417","volume":"58","author":"A Ohkuchi","year":"2011","unstructured":"Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y, Suzuki M. Threshold of soluble fms-like tyrosine kinase 1\/placental growth factor ratio for the imminent onset of preeclampsia. Hypertension. 2011;58:859\u201366.","journal-title":"Hypertension"},{"key":"2428_CR29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/hr.2013.95","volume":"36","author":"A Ohkuchi","year":"2013","unstructured":"Ohkuchi A, Hirashima C, Takahashi K, Suzuki H, Matsubara S, Suzuki M. Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation. Hypertens Res. 2013;36:1073\u201380.","journal-title":"Hypertens Res"},{"key":"2428_CR30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1291\/hypres.28.727","volume":"28","author":"C Hirashima","year":"2005","unstructured":"Hirashima C, Ohkuchi A, Arai F, Takahashi K, Suzuki H, Watanabe T, et al. Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women. Hypertens Res. 2005;28:727\u201332.","journal-title":"Hypertens Res"},{"key":"2428_CR31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.preghy.2018.03.008","volume":"12","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Hirashima C, Nagayama S, Takahashi K, Yamamoto T, Matsubara S, et al. Increased serum levels of sFlt-1\/PlGF ratio in preeclamptic women with onset at <32weeks compared with \u226532weeks. Pregnancy Hypertens. 2018;12:96\u2013103.","journal-title":"Pregnancy Hypertens"},{"key":"2428_CR32","doi-asserted-by":"crossref","first-page":"e0240473","DOI":"10.1371\/journal.pone.0240473","volume":"15","author":"B Mitlid-Mork","year":"2020","unstructured":"Mitlid-Mork B, Bowe S, Gran JM, Bolstad N, Berg JP, Redman CW, et al. Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: a prospective observational study. PLoS One. 2020;15:e0240473.","journal-title":"PLoS One"},{"key":"2428_CR33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jog.13786","volume":"45","author":"H Suzuki","year":"2019","unstructured":"Suzuki H, Nagayama S, Hirashima C, Takahashi K, Takahashi H, Ogoyama M, et al. Markedly higher sFlt-1\/PlGF ratio in a woman with acute fatty liver of pregnancy compared with HELLP syndrome. J Obstet Gynaecol Res. 2019;45:96\u2013103.","journal-title":"J Obstet Gynaecol Res"},{"key":"2428_CR34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13730-018-0373-7","volume":"8","author":"C Hirashima","year":"2019","unstructured":"Hirashima C, Ogoyama M, Abe M, Shiraishi S, Sugase T, Niki T, et al. Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy. CEN Case Rep. 2019;8:95\u2013100.","journal-title":"CEN Case Rep"},{"key":"2428_CR35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14390\/jsshp.HRP2024-002","volume":"12","author":"A Ohkuchi","year":"2024","unstructured":"Ohkuchi A, Suzuki H, Otachi H, Hirashima C, Takahashi K, Takahashi H. Isolated HELLP syndrome without hypertension or proteinuria exhibiting increases in serum levels of both PlGF and sFlt-1. Hypertens Res Pregnancy. 2024;12:92\u20137.","journal-title":"Hypertens Res Pregnancy"},{"key":"2428_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.14390\/jsshp.HRP2018-014","volume":"6","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Matsubara K, Nakamoto O, Ushijima J, Ohkuchi A, Koide K, et al. Outline of the new definition and classification of \u201cHypertensive Disorders of Pregnancy (HDP)\u201d; a revised JSSHP statement of 2005. Hypertens Res Pregnancy. 2018;6:33\u20137.","journal-title":"Hypertens Res Pregnancy"},{"key":"2428_CR37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1447-0756.2011.01653.x","volume":"37","author":"H Minakami","year":"2011","unstructured":"Minakami H, Hiramatsu Y, Koresawa M, Fujii T, Hamada H, Iitsuka Y, et al. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition. J Obstet Gynaecol Res. 2011;37:1174\u201397.","journal-title":"J Obstet Gynaecol Res"},{"key":"2428_CR38","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0002-9378(87)80278-8","volume":"157","author":"N Shinozuka","year":"1987","unstructured":"Shinozuka N, Okai T, Kohzuma S, Mukubo M, Shih CT, Maeda T, et al. Formulas for fetal weight estimation by ultrasound measurements based on neonatal specific gravities and volumes. Am J Obstet Gynecol. 1987;157:1140.","journal-title":"Am J Obstet Gynecol"},{"key":"2428_CR39","unstructured":"Taiji Tyouonpa no Keisoku: Hyoujunka to Nihonjin no Kijunti [Standardization of ultrasound fetal measurements and reference values for Japanese people]. Nihon Sanka Fujinka Gakkai Zasshi. 2005;57:93\u2013117."},{"key":"2428_CR40","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","volume":"206","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206:58.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"2428_CR41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/jpm-2012-0248","volume":"41","author":"W Schaarschmidt","year":"2013","unstructured":"Schaarschmidt W, Rana S, Stepan H. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med. 2013;41:511\u20136.","journal-title":"J Perinat Med"},{"key":"2428_CR42","volume":"2019","author":"WZ Lou","year":"2019","unstructured":"Lou WZ, Jiang F, Hu J, Chen XX, Song YN, Zhou XY, et al. Maternal serum angiogenic factor sFlt-1 to PlGF ratio in preeclampsia: a useful marker for differential diagnosis and prognosis evaluation in Chinese women. Dis Markers. 2019;2019:6270187.","journal-title":"Dis Markers"},{"key":"2428_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.preghy.2020.01.009","volume":"19","author":"S Enengl","year":"2020","unstructured":"Enengl S, Mayer RB, Le Renard PE, Shebl O, Arzt W, Oppelt P. Retrospective evaluation of established cut-off values for the sFlt-1\/PlGF ratio for predicting imminent delivery in preeclampsia patients. Pregnancy Hypertens. 2020;19:143\u201349.","journal-title":"Pregnancy Hypertens"},{"key":"2428_CR44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.119.13997","volume":"75","author":"H Perry","year":"2020","unstructured":"Perry H, Binder J, Kalafat E, Jones S, Thilaganathan B, Khalil A. Angiogenic marker prognostic models in pregnant women with hypertension. Hypertension. 2020;75:755\u201361.","journal-title":"Hypertension"},{"key":"2428_CR45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.preghy.2021.02.012","volume":"24","author":"KE Duhig","year":"2021","unstructured":"Duhig KE, Seed PT, Placzek A, Sparkes J, Hendy E, Gill C, et al. Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: the PEACOCK study. Pregnancy Hypertens. 2021;24:90\u20135.","journal-title":"Pregnancy Hypertens"},{"key":"2428_CR46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/hr.2010.15","volume":"33","author":"A Ohkuchi","year":"2010","unstructured":"Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, et al. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010;33:422\u20137.","journal-title":"Hypertens Res"},{"key":"2428_CR47","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/1471-0528.17240","volume":"129","author":"A Arechvo","year":"2022","unstructured":"Arechvo A, Voicu D, Gil MM, Syngelaki A, Akolekar R, Nicolaides KH. Maternal race and pre-eclampsia: cohort study and systematic review with meta-analysis. BJOG. 2022;129:2082\u201393.","journal-title":"BJOG"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02428-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02428-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02428-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:02:02Z","timestamp":1764889322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02428-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02428-0","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}